Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recovery after stem-cell transplantation for hematologic diseases.

S J Lee1, D Fairclough, S K Parsons

  • 1Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. stephanie_lee@dfci.harvard.edu

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|January 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of video vector analysis of ankle foot orthoses in children with physical disability: A 10-year clinical review.

Gait & posture·2024
Same author

Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition.

Clinical and experimental dermatology·2018
Same author

Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study.

Oral diseases·2017
Same author

Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.

Bone marrow transplantation·2017
Same author

Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.

Bone marrow transplantation·2017
Same author

Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?

Bone marrow transplantation·2016

Recovery after stem-cell transplantation (SCT) shows encouraging trends, with most patients experiencing fewer bothersome symptoms and continued improvement through the first year post-transplant. These findings aid in setting realistic expectations for patients undergoing SCT.

Area of Science:

  • Hematology
  • Oncology
  • Transplant Medicine

Background:

  • Stem-cell transplantation (SCT) is increasingly utilized for hematologic malignancies and other disorders.
  • Limited quantitative data exists regarding patient recovery and quality of life post-SCT, hindering effective patient counseling.

Purpose of the Study:

  • To establish reasonable expectations for recovery and symptom burden following autologous and allogeneic SCT.
  • To assess recovery using objective health status measures, quality of life indicators, and specific symptom quantification.

Main Methods:

  • A prospective, longitudinal questionnaire study was conducted.
  • Participants included recipients of autologous and allogeneic SCT at a tertiary-care transplant center.
  • Response rates among survivors at 6, 12, and 24 months ranged from 85% to 88%.

Related Experiment Videos

Main Results:

  • While autologous SCT recipients initially showed better survival and recovery, differences largely equalized by 12 months post-transplant.
  • Less than 24% of patients reported bothersome symptoms, excluding fatigue, financial, and sexual difficulties.
  • Continued recovery and a low level of bothersome symptoms were observed through the first year.

Conclusions:

  • Findings provide valuable insights for counseling patients considering SCT, outlining realistic recovery expectations.
  • The study highlights encouraging trends in symptom reduction and overall recovery within the first year after SCT.